Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * MINOGUE MICHAEL R	2. Issuer Name and Ticker or Trading Symbol ABIOMED INC [ ABMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chairman, President, CEO
(Last)          (First)          (Middle) C/O ABIOMED, INC.,, 22 CHERRY HILL DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 5/15/2020
(Street) DANVERS, MA 01923 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock $.01 par value	5/15/2020		F(5)		8506 (5)	D	$184.27	229303	D
Common Stock $.01 par value	5/15/2020		F(5)		2063 (5)	D	$184.27	227240	D
Common Stock $.01 par value	5/16/2020		F(5)		1632 (5)	D	$184.92	225608	D
Common Stock $.01 par value	5/16/2020		F(5)		4546 (5)	D	$184.92	221062	D
Common Stock $.01 par value								31672	I	By Trust - A
Common Stock $.01 par value								32810	I	By Trust - C
Common Stock $.01 par value								73745	I	By Trust - B
Common Stock $.01 par value								655	I	By Trust - D
Common Stock $.01 par value								38560	I	By Trust - E
Common Stock $.01 par value								85040	I	By Trust - F

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy) (2)	$22.44							5/22/2013 (1)	5/22/2022	Common Stock	0		100000	D
Stock Option (Right to Buy) (2)	$23.15							5/14/2014 (1)	5/14/2023	Common stock	0		85000	D
Stock Option (right to buy) (2)	$21.55							5/14/2015 (3)	5/14/2024	Common Stock	0		85000	D
Stock Option (right to buy) (2)	$66.25							5/13/2016 (3)	5/13/2025	Common Stock	0		35000	D
Stock Option (right to buy) (4)	$99.62							5/24/2017 (3)	5/24/2026	Common Stock	0		30500	D
Stock Option (right to buy) (4)	$134.51							5/15/2018 (3)	5/15/2027	Common Stock	0		33000	D
Stock Option (right to buy) (4)	$381.97							5/16/2019 (3)	5/16/2028	Common Stock	0		30000	D
Stock Option (right to buy) (4)	$266.39							5/30/2020 (3)	5/30/2029	Common Stock	0		50000	D

Explanation of Responses:
(1)	These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
(2)	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
(3)	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
(4)	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
(5)	Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
MINOGUE MICHAEL R C/O ABIOMED, INC., 22 CHERRY HILL DRIVE DANVERS, MA 01923	X		Chairman, President, CEO

Signatures
/s/ Ian W. McLeod (by power of attorney)		5/19/2020
**Signature of Reporting Person		Date